Casein Kinase 2α Regulates Glioblastoma Brain Tumor Initiating Cell Growth through the β-Catenin Pathway

Glioblastoma (GBM) is the most common and fatal primary brain tumor in humans and it is essential that new and better therapies are developed to treat this disease. Previous research suggests that casein kinase 2 (CK2), may be a promising therapeutic target for GBMs. CK2 has enhanced expression or a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitta, Ryan T., Gholamin, Sharareh, Feroze, Abdullah H., Agarwal, Maya, Cheshier, Samuel H., Mitra, Siddhartha S., Li, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369469/
https://www.ncbi.nlm.nih.gov/pubmed/25241897
http://dx.doi.org/10.1038/onc.2014.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369469/
https://www.ncbi.nlm.nih.gov/pubmed/25241897
http://dx.doi.org/10.1038/onc.2014.299

Ejemplares similares